Diaceutics PLC
LSE:DXRX
Diaceutics PLC
LSE:DXRX
Price:
152
GBX
1%
Market Closed
Market Cap:
£129m
Relative Value
The Relative Value of one
DXRX
stock under the Base Case scenario is
hidden
GBX.
Compared to the current market price of 152 GBX,
Diaceutics PLC
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
DXRX Relative Value
HIDDEN
Multiples Across Competitors
DXRX Competitors Multiples
Diaceutics PLC Competitors
Diaceutics PLC Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| UK |
|
Diaceutics PLC
LSE:DXRX
|
127.3m GBP | 3.7 | -84.6 | 39.6 | -58.1 | |
| US |
P
|
PerkinElmer Inc
LSE:0KHE
|
1.1T USD | 368.3 | 4 361 | 1 382.7 | 2 954.2 | |
| US |
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
195.3B USD | 4.4 | 29.1 | 20.3 | 27.3 | |
| US |
|
Danaher Corp
NYSE:DHR
|
147.9B USD | 6 | 40.9 | 22.7 | 34.5 | |
| KR |
|
Samsung Biologics Co Ltd
KRX:207940
|
79.2T KRW | 14.4 | 49.6 | 29.1 | 38.8 | |
| CH |
|
Lonza Group AG
SIX:LONN
|
36.7B CHF | 5.6 | 38.7 | 28.6 | 28.6 | |
| CN |
|
WuXi AppTec Co Ltd
SSE:603259
|
280.9B CNY | 6.3 | 18.7 | 18.9 | 18.9 | |
| US |
|
Agilent Technologies Inc
NYSE:A
|
34.3B USD | 4.9 | 26.3 | 19.2 | 22.8 | |
| US |
|
IQVIA Holdings Inc
NYSE:IQV
|
29.9B USD | 1.8 | 22 | 12.1 | 18.2 | |
| US |
|
Mettler-Toledo International Inc
NYSE:MTD
|
27.8B USD | 6.9 | 32 | 23.6 | 26.2 | |
| CN |
|
WuXi Biologics (Cayman) Inc
HKEX:2269
|
164.2B HKD | 7.2 | 34.4 | 24.1 | 24.1 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
